Abstract

IntroductionWHO now recommends test-based management of malaria (TBMM) across all age-groups. This implies artemisinin-based combination treatment (ACT) should be restricted to rapid diagnostic test (RDT)-positive cases. This is a departure from what caregivers in rural communities have been used to for many years.MethodsWe conducted a survey among caregivers living close to 32 health centres in six districts in rural Ghana and used logistic regression to explore factors likely to influence caregiver acceptability of RDT based case management and concern about the denial of ACT on account of negative RDT results. Focus group discussions were conducted to explain the quantitative findings and to elicit further factors.ResultsA total of 3047 caregivers were interviewed. Nearly all (98%) reported a preference for TBMM over presumptive treatment. Caregivers who preferred TBMM were less likely to be concerned about the denial of ACT to their test-negative children (O.R. 0.57, 95%C.I. 0.33–0.98). Compared with caregivers who had never secured national health insurance cover, caregivers who had valid (adjusted O.R. 1.30, 95% CI 1.07–1.61) or expired (adjusted O.R. 1.38, 95% CI 1.12–1.73) insurance cover were more likely to be concerned about the denial of ACT to their RDT-negative children. Major factors that promote TBMM acceptability include the perception that a blood test at health centre level represents improvement in the quality of care, leads to improvement in treatment outcomes, and offers opportunity for better communication between health workers and caregivers. Acceptability is also enhanced by engaging caregivers in the procedures of the test. Apprehensions about negative health worker attitude could however undermine acceptance.ConclusionTest (RDT)-based management of malaria in under-five children is likely to be acceptable to caregivers in rural Ghana. The quality of caregiver-health worker interaction needs to be improved if acceptability is to be sustained.

Highlights

  • World Health Organisation (WHO) recommends test-based management of malaria (TBMM) across all age-groups

  • Arguments in favour of the shift to test-based management of malaria include: malaria transmission has been declining in areas previously considered to be very high; due to emergence of resistance cheap antimalarials have been replaced with the relatively more expensive artemisinin-based combination therapy (ACT); smear microscopy is no longer the only means of confirming the diagnosis of malaria since accurate and reliable rapid diagnostic tests (RDTs) are available; a policy of test-based management of malaria will lead to improvement in the management of nonmalaria febrile illnesses within the context of Integrated Management of Childhood Illnesses (IMCI) [8,9]

  • This fell short of the target 3200 caregivers because some health centres were situated in communities that had less than 100 children under two years of age who lived within 2 kilometres of the centre

Read more

Summary

Introduction

WHO recommends test-based management of malaria (TBMM) across all age-groups This implies artemisinin-based combination treatment (ACT) should be restricted to rapid diagnostic test (RDT)-positive cases. Arguments in favour of the shift to test-based management of malaria include: malaria transmission has been declining in areas previously considered to be very high; due to emergence of resistance cheap antimalarials have been replaced with the relatively more expensive artemisinin-based combination therapy (ACT); smear microscopy is no longer the only means of confirming the diagnosis of malaria since accurate and reliable rapid diagnostic tests (RDTs) are available; a policy of test-based management of malaria will lead to improvement in the management of nonmalaria febrile illnesses within the context of IMCI [8,9]

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call